SS
Sanjay Sahabal Yadav
About Sanjay Sahabal Yadav
Data last updated:
Sanjay Sahabal Yadav is a Director at Dzyris Pharmaceuticals Private Limited (since 2021) and Designated Partner at Urbanhome Advisors Llp (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Dzyris Pharmaceuticals Private Limited at ₹1.2 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dzyris Pharmaceuticals Private Limited U51909MH2021PTC360043 | Director | 07 May 2021 | 2021 | ₹1.2 Lakh (FY 2023) | Active |
 Urbanhome Advisors Llp ACL-7068 | Designated Partner | 28 Jan 2025 | 2025 | Active |
Board colleagues of Sanjay Sahabal Yadav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jeetendra Yadav | 09168075 | Dzyris Pharmaceuticals Private Limited | Director |
| Nitin Bhimashankar Gopale | 10943374 | Dzyris Pharmaceuticals Private Limited | Director |
| Rakesh Kumar Yadav | 08660858 | Dzyris Pharmaceuticals Private Limited | Director |
| Babita Uttamrao Wankhade | 10928058 | Urbanhome Advisors Llp | Designated Partner |
| Roopesh Agarwal | 07528036 | Urbanhome Advisors Llp | Designated Partner |
| Sushma Sudhakar Jadhav | 10928059 | Urbanhome Advisors Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Sahabal Yadav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Sahabal Yadav
Sanjay Sahabal Yadav currently holds 2 directorships: Dzyris Pharmaceuticals Private Limited (Director, since 07 May 2021, revenue ₹1.2 Lakh (FY 2023)); Urbanhome Advisors Llp (Designated Partner, since 28 Jan 2025).
Sanjay Sahabal Yadav was first appointed on 07 May 2021 as Director at Dzyris Pharmaceuticals Private Limited. The most recent appointment on record is 28 Jan 2025 at Urbanhome Advisors Llp.
The current boards of Sanjay Sahabal Yadav's companies include Jeetendra Yadav (Dzyris Pharmaceuticals Private Limited), Nitin Bhimashankar Gopale (Dzyris Pharmaceuticals Private Limited), Rakesh Kumar Yadav (Dzyris Pharmaceuticals Private Limited), Babita Uttamrao Wankhade (Urbanhome Advisors Llp), Roopesh Agarwal (Urbanhome Advisors Llp), Sushma Sudhakar Jadhav (Urbanhome Advisors Llp).